Ardent Health Reports Strong Q1 Results with 26% Adjusted EBITDA Growth; Reaffirms Full-Year Guidance
ARDT sits 30% above its 52-week low of $8.07.
Summary
Ardent Health, Inc. announced strong first-quarter 2026 financial results, including a 7.0% increase in total revenue and a 26.3% rise in Adjusted EBITDA, while reaffirming its full-year guidance.
Key Events · Earnings and Guidance · ARDT
-
Strong Q1 Financial Performance
Total revenue increased 7.0% year-over-year to $1.60 billion, and Adjusted EBITDA grew 26.3% year-over-year to $124 million for the first quarter ended March 31, 2026.
-
Full-Year Guidance Reaffirmed
The company reaffirmed its full-year 2026 financial guidance, projecting total revenue between $6,400 million and $6,700 million and Adjusted EBITDA between $485 million and $535 million.
-
Operational Growth Despite Headwinds
Adjusted admissions increased by 2.0% and total surgeries grew by 1.2% year-over-year, despite a slight decrease in overall admissions attributed to severe weather and a lighter respiratory season.
Analysis · ARDT · Industrial Applications And Services
Ardent Health, Inc. delivered a robust first quarter, marked by significant growth in Adjusted EBITDA and revenue, which signals strong operational execution. The reaffirmation of full-year guidance, despite some transient seasonal volume impacts, indicates management's confidence in sustained performance. This positive financial update, following closely on the heels of a Reuters report, provides investors with detailed confirmation of the company's solid start to the year and its outlook.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ARDT was trading at $10.50 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $8.07 to $15.48. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.